[Clinical and pathological characteristics of focal segmental glomerulosclerosis in children]

Jian-ping Huang1, Jing-jing Zhang, Jing-cheng Liu

  • 1Department of Pediatrics, Peking University First Hospital, Beijing 100034, China.

Insights

Focal segmental glomerulosclerosis (FSGS) is common in school-aged children, often presenting as nephrotic syndrome. Combination therapies like pulse methylprednisolone and cyclosporin A show promising remission rates for pediatric FSGS.

Area of Science:

  • Pediatric Nephrology
  • Glomerular Diseases
  • Renal Pathology

Context:

  • Focal segmental glomerulosclerosis (FSGS) is a significant cause of kidney disease in children.
  • Understanding the clinical and pathological spectrum of pediatric FSGS is crucial for effective management.
  • This study retrospectively analyzed 38 pediatric FSGS cases.

Purpose:

  • To investigate the clinical and pathological characteristics of primary focal segmental glomerulosclerosis (FSGS) in children.
  • To evaluate treatment responses and identify factors influencing outcomes in pediatric FSGS.

Summary:

  • The study included 38 children (25 boys, 13 girls) aged 1.5–15 years with primary FSGS.
  • Nephrotic syndrome was the predominant presentation (34 cases), with hematuria common (63%).
  • Tip variant FSGS was associated with simple nephrotic syndrome, while diffuse mesangial hypercellularity correlated with hematuria.
  • Pulse methylprednisolone and pulse cyclophosphamide or cyclosporin A showed good response rates (83% remission).
  • Proteinuria levels post-treatment correlated with tubulointerstitial lesions and renal function.

Impact:

  • Highlights the commonality of FSGS in school-aged children and its varied presentations.
  • Suggests that specific FSGS variants have distinct clinical features.
  • Indicates the efficacy of intensive immunosuppressive therapies in achieving remission in pediatric FSGS.
  • Emphasizes the correlation between post-treatment proteinuria and long-term renal health.
Abstract